BioSpace News Archive

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the quarter ended June 30, 2019, after the close of market on Thursday August 8, 2019.

DexCom, Inc. reported its financial results as of and for the quarter ended June 30, 2019.

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported financial results for the second quarter ended June 28, 2019.

Companies will partner to advance small molecules in up to six discrete projects, including three existing programs against specific predetermined targets

CRH Medical Corporation, announced its financial and operating results for the three months ended June 30, 2019.

STAAR Surgical Company announced the submission of its multi-site European pivotal clinical trial data for the EVO+ Visian® ICL with Aspheric Optic, a lens that is designed to provide correction or reduction of myopia or hyperopia and presbyopia.

McKesson Corporation reported that revenues for the first quarter ended June 30, 2019, were $55.7 billion compared to $52.6 billion a year ago, an increase of 6% on a reported basis and an increase of 7% on an FX-adjusted basis.

Sangamo Therapeutics, Inc., a genomic medicine company, announced the appointment of Gary H. Loeb as Executive Vice President and General Counsel, effective immediately.

Portage Biotech Inc. announced that, further to its news release of July 26, 2019, it will be delayed in filing its audited annual financial statements for the year ended March 31, 2019, the related management’s discussion and analysis and certificates of its CEO and CFO with Canadian securities regulators until after deadline.

Citizens Against Government Waste President Tom Schatz issued a statement regarding the Department of Health and Human Service’s proposal to allow the importation of drugs originally intended for sale in foreign countries.